March 26, 2015
(ANTIMEDIA) Since the 60’s, a common misconception about psychedelic drugs has infiltrated the public eye. Horror stories about young teens taking LSD and jumping to their death and anti-drug propaganda have created a distorted link between psychedelic drugs and psychosis. However, two researchers in Norway suggest that this belief is indeed false.
Pål-Ørjan Johansen and Teri Suzanne Krebs of the Norwegian University of Science and Technology in Trondheim analyzed data collected from the US National Survey on Drug Use and Health. Of the 135,000+ people that participated in the survey, approximately 14% of them confirmed that they had used psychedelic substances (in this case, LSD, psilocybin, or mescaline) at some point in their lives.
Johansen and Krebs found that there isn’t a legitimate correlation between psychedelic drugs and mental health complications. In fact, not only was there no proof of causation, the data also suggests that psychedelics may have been involved in lowering the rate of psychosis. The full publication can be read here.
This shouldn’t come as a surprise to some — considering how many significant discoveries have been made involving psychedelics in the medical field. In addition to researchers finding that psychedelic drugs may be highly effective in psychotherapy, they’re also finding that they’re effective in treating some chronic illnesses.
A man named Bob Wold is a strong advocate for psychedelic medicine, and for good reason. Bob suffers from cluster headaches or “suicide headaches”. For those not familiar with this condition, cluster headaches are reoccurring headaches that cause excruciating pain usually on one side of the head and can leave a person completely inhibited for anywhere from 15 minutes to 3 hours.
Bob had tried around 70 different medications for his condition, none of which worked. But after he discovered that LSD sent his CH attacks into remission, he founded Clusterbusters, an organization dedicated to helping patients with cluster headaches.
Of course, a potential downside to this is the actual psychedelic aspect to it. Some people simply don’t like drugs, but love living without an ice pick in their skull. Nonetheless, this isn’t a problem either.
Clusterbusters contacted Dr. John Halpern, Assistant Professor of Psychiatry at Harvard Medical School for clinical trials. Although Halpern agreed, obtaining LSD for study would obviously prove to be difficult. Instead, Halpern took his research to Germany and used non-hallucinogenic 2-Bromo-LSD on the subjects. Non-hallucinogenic 2-Bromo-LSD has a very similar chemical structure to LSD, however the hallucinogenic effects are not felt. Sure enough, the treatment worked.
The same results have been found in CH patients with psilocybin or “magic mushrooms”. This man is living proof of it.
A life-ruining disease put into remission by hallucinogenic drugs. Go figure.
This article is free and open source. You have permission to republish this article under a Creative Commons license with attribution to the author and TheAntiMedia.org. Tune in to the Anti-Media radio show Monday through Friday @ 11pm Eastern/8pm Pacific. Image credit: Kaylene McLaughlin. Help us fix our typos: email@example.com.
Since you’re here…
…We have a small favor to ask. Fewer and fewer people are seeing Anti-Media articles as social media sites crack down on us, and advertising revenues across the board are quickly declining. However, unlike many news organizations, we haven’t put up a paywall because we value open and accessible journalism over profit — but at this point, we’re barely even breaking even. Hopefully, you can see why we need to ask for your help. Anti-Media’s independent journalism and analysis takes substantial time, resources, and effort to produce, but we do it because we believe in our message and hope you do, too.
If everyone who reads our reporting and finds value in it helps fund it, our future can be much more secure. For as little as $1 and a minute of your time, you can support Anti-Media. Thank you. Click here to support us